Ir al contenido
Georgia Commons

Código Oficial de Georgia Anotado

Título 49. SOCIAL SERVICES · Capítulo 4. PUBLIC ASSISTANCE · Artículo 7. MEDICAL ASSISTANCE GENERALLY

49-4-159.4. Coverage for continuous glucose monitors.

Vigente

Actualizado hasta: Including Acts of the 2025 Regular Session of the General Assembly.

El texto siguiente es la ley tal como la imprime el estado, en inglés.

  1. (a)

    On and after July 1, 2025, the department shall include coverage for continuous glucose monitors as a benefit under Medicaid via the most cost-effective benefit delivery channel. The criteria for such coverage shall be updated to align with current standards of care and shall include, but shall not be limited to, requirements that:#

    1. (1)

      The recipient has been diagnosed with diabetes mellitus by a treating practitioner;#

    2. (2)

      The recipient’s treating practitioner has concluded that the recipient or the recipient’s caregiver has had sufficient training in using a continuous glucose monitor as evidenced by the provision of a prescription therefor; and#

    3. (3)

      The recipient:#

      1. (A)

        Is treated with at least one daily administration of insulin;#

      2. (B)

        Has gestational diabetes; or#

      3. (C)

        Has a history of problematic hypoglycemia with documentation of at least one of the following:#

        1. (i)

          Recurrent level 2 hypoglycemic events (glucose less than 54 mg/dL (3.0 mmol/L)) that persist despite two or more attempts to adjust medication, modify the diabetes treatment plan, or both; or#

        2. (ii)

          A history of a level 3 hypoglycemic event (glucose less than 54 mg/dL (3.0 mmol/L)) characterized by altered mental or physical state requiring third-party assistance for treatment for hypoglycemia.#

  2. (b)

    Within six months prior to prescribing a continuous glucose monitor for a recipient, the treating practitioner shall have had an in-person or telehealth visit with the recipient to evaluate the recipient’s diabetes control and shall have concluded that the recipient meets the criteria set forth in subsection (a) of this Code section.#

  3. (c)

    Every six months following the initial prescription of a continuous glucose monitor, the treating practitioner shall have an in-person or telehealth visit with the recipient to assess adherence to his or her continuous glucose monitor regimen and diabetes treatment plan.#

Las notas siguientes se imprimen con la sección, pero no son ley promulgada (O.C.G.A. § 1-1-1(c)). Se muestran aparte del texto.

History

Code 1981, § 49-4-159.4, enacted by Ga. L. 2024, p. 911, § 1/SB 35, effective July 1, 2024; Ga. L. 2025, p. 641, § 2/HB 352, effective July 1, 2025.

Effective date

This Code section became effective July 1, 2024. See Editor’s notes for effective date.

Amendments

The 2025 amendment, effective July 1, 2025, substituted “July 1, 2025” for “July 1, 2023” in the first sentence of subsection (a); deleted “or” at the end of subparagraph (a)(3)(A); added subparagraph (a)(3)(B); and redesignated former subparagraph (a)(3)(B) as subparagraph (a)(3)(C).

Editor's notes

Ga. L. 2024, p. 911, § 1/SB 35, approved by the Governor on May 6, 2024, provided that the effective date of this Code section is July 1, 2023. See Op. Att’y Gen. No. 76-76 for construction of effective date provisions that precede the date of approval by the Governor. Ga. L. 2025, p. 641, § 1/HB 352, not codified by the General Assembly, provides: “This Act shall be known and may be cited as the ‘Georgia Gestational Diabetes Management Act.’”

Code Commission notes

Pursuant to Code Section 28-9-5, in 2024, Code Section 49-4-159.2, as enacted by Ga. L. 2024, p. 911, § 1/SB 35, was redesignated as Code Section 49-4-159.4.

Cross references

Georgia Diabetes Control Grant Program, § 31-2A-14.

Leer la página oficial (el PDF del estado, abierto en la página de la que se leyó este texto).

Actualizado hasta: Including Acts of the 2025 Regular Session of the General Assembly.

Texto leído de t49-t50-ch1-12-(v38)-pdf.pdf, Volumen V38, edición 2023, suplemento de 2025, páginas 11 a 13; acción de fusión: added; SHA-256 del archivo 2a8229331844.